U.S. News | Omni MedSci Accuses Dexcom over Mobile Glucose Monitoring Systems Patent Infringement

Image Credit: © Bjørn Hovdal | Dreamstime.com

Late last month, a Michigan company, Omni MedSci Inc. filed a lawsuit against a San Diego Company, Dexcom Inc., in the U.S. District Court for the Southern District of California with case number 3:18-cv-01653 alleging patent infringement.

The Michigan Company accused the defendant of infringing two of its patent which was assigned by U.S Patents and Trademarks Office; patent nos. ‘174 and ‘402 by their named inventor.

The plaintiff alleges that the defendants G4 and G5 mobile continuous glucose monitoring systems infringes these patents thereby causing unfair competition, confusion and demise of integrity.

The plaintiff requests a trial by jury and seeks judgment against defendant for damages from infringement of the ‘174 and ‘402 patents, injunctive relief, attorney’s fees, costs and disbursements, and all other relief to which plaintiff is entitled.


Omni MedSci Inc. Vs Dexcom Inc.

Court – U.S. District Court for the Southern District of California

Filling Date – July 20th, 2018

Case # – 3:18-cv-01653

Cause – Infringement

Case – Patent Infringement

Plaintiff Representation – William E. Thomson Jr. of Brooks Kushman PC

Print Friendly, PDF & Email
About Nathaniel Adebayo 272 Articles
Nathaniel is a News Reporting Intern at Nigerian Law Intellectual Property Watch (NLIPW). He has a passion for writing, capacity building and social media marketing. He is a graduate of Federal University of Technology, Minna, where he graduated with BTECHAGRIC. He is a member of Soil Science Society of Nigeria (SSSN) and the National Union of Campus Journalist (NUCJ). Nathaniel has served as Editor-in-Chief for a number of magazines and as a contributor to various online repositories. Email: anathaniel@nlipw.com

Be the first to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.